Cargando…
Neurometabolite changes in response to antidepressant medication: A systematic review of (1)H-MRS findings
Selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and (es)ketamine are used to treat major depressive disorder (MDD). These different types of medication may involve common neural pathways related to glutamatergic and GABAergic neurotransmitter...
Autores principales: | Boucherie, Daphne E., Reneman, Liesbeth, Ruhé, Henricus G., Schrantee, Anouk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563053/ https://www.ncbi.nlm.nih.gov/pubmed/37812859 http://dx.doi.org/10.1016/j.nicl.2023.103517 |
Ejemplares similares
-
Neurometabolite Changes in Hyperthyroid Patients Before and After Antithyroid Treatment: An in vivo
(1)H MRS Study
por: Kumar, Mukesh, et al.
Publicado: (2021) -
On the Effect of Sex on Prefrontal and Cerebellar Neurometabolites in Healthy Adults: An MRS Study
por: Endres, Dominique, et al.
Publicado: (2016) -
(1)H-MRS neurometabolites and associations with neurite microstructures and cognitive functions in amnestic mild cognitive impairment
por: Gozdas, Elveda, et al.
Publicado: (2022) -
The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review
por: Sørensen, Anders, et al.
Publicado: (2021) -
The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
por: Klomp, Anne, et al.
Publicado: (2012)